Inventor · disambiguated record
Mark S. Smyth
Also filed as: SMYTH MARK · SMYTH MARK S · SMYTH MARK STEPHEN
41 granted patents·45 pending applications·1,162 citations·filing 1992–2024
99Inventor score
Top patents by PatentIndex Score
86 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0398US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0498US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0598US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0698US8207297B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Jun 26, 2012·49 cites·24 claims
- 0798US8207125B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Jun 26, 2012·42 cites·30 claims
- 0898US7691852B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2007·Granted Apr 6, 2010·65 cites·4 claims
- 0998US7417042B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2005·Granted Aug 26, 2008·85 cites·37 claims
- 1098US7232818B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2005·Granted Jun 19, 2007·88 cites·50 claims
- 1197US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 1297US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 1397US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 1497US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1597US8431571B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Apr 30, 2013·33 cites·46 claims
- 1697US8357683B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2011·Granted Jan 22, 2013·34 cites·22 claims
- 1797US8207126B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Jun 26, 2012·39 cites·21 claims
- 1897US8207127B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Jun 26, 2012·37 cites·27 claims
- 1997US7491704B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2007·Granted Feb 17, 2009·57 cites·48 claims
- 2096US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 2196US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 2296US8324174B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Dec 4, 2012·28 cites·27 claims
- 2396US8207124B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2011·Granted Jun 26, 2012·29 cites·30 claims
- 2496US8129346B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2005·Granted Mar 6, 2012·38 cites·62 claims
- 2596US8080576B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·37 cites·30 claims
- 2696US8080545B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·35 cites·17 claims
- 2795US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 2895US9012463B2Inhibitors of bruton's tyrosine kinaseCHEN WEI·Filed 2010·Granted Apr 21, 2015·41 cites·14 claims
- 2995US8198270B2Compounds for proteasome enzyme inhibitionSMYTH MARK S·Filed 2005·Granted Jun 12, 2012·29 cites·6 claims
- 3095US8088741B2Compounds for enzyme inhibitionSMYTH MARK S·Filed 2005·Granted Jan 3, 2012·43 cites·20 claims
- 3194US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 3291US7115741B24-thieno[2,3-D]pyrimidin-4-YL piperazine compoundsLEVY DANIEL E·Filed 2002·Granted Oct 3, 2006·41 cites·19 claims
- 3390US8609654B1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 17, 2013·8 cites·60 claims
- 3488US2025197404A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 3588US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 3684US2022267372A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2022·Application pending·0 cites
- 3784US2024158400A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 3881US6552079B2Integrin antagonistsLILLY CO ELI·Filed 2001·Granted Apr 22, 2003·10 cites·23 claims
- 3979US2022112196A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 4078US2021179663A1Compounds for proteasome enzyme inhibitionONYX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4177US2021032258A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 4276US8765745B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Jul 1, 2014·1 cites·100 claims
- 4376US2020325172A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2020·Application pending·0 cites
- 4476US2019248799A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 4576US2019248798A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 4675US2020347063A1Solvated forms of a bruton?s tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 4775US2020231595A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 4875US2020148691A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 4974US2020071356A1Compounds for proteasomeONYX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5073US2022098200A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →